Inhibition of cannabinoid CB1 receptor upregulates Slc2a4 expression via nuclear factor-κB and sterol regulatory element-binding protein-1 in adipocytes

Journal of Molecular Endocrinology

Volumn 49, Issue 2, 2012, Pages 97-106

  Furuya, D T ^a   Poletto, A C ^a   Freitas, H S ^a   Machado, U F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR AGONIST; CANNABINOID 1 RECEPTOR ANTAGONIST; GLUCOSE TRANSPORTER 4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ADIPOCYTE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONTENT; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; ARACHIDONIC ACIDS; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORTER TYPE 4; MICE; NF-KAPPA B; PIPERIDINES; PROMOTER REGIONS, GENETIC; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; UP-REGULATION;

EID: 84866406303     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-12-0037     Document Type: Article

References (37)

1. Bellocchio L, Cervino C, Vicennati V, Pasquali R & Pagotto U 2008 Cannabinoid type 1 receptor: another arrow in the adipocytes' bow. Journal of Neuroendocrinology 20 (Suppl 1) 130-138. (doi:10.1111/j. 1365-2826.2008.01682.x)
2. Börner C, Hö llt V, Sebald W & Kraus J 2007 Transcriptional regulation of the cannabinoid receptor type 1 gene in Tcells by cannabinoids. Journal of Leukocyte Biology 81 336-343. (doi:10.1189/jlb.0306224)
3. Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, Rouault C, Coupaye M, Pelloux V, Hugol D, Bouillot JL et al. 2005 Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 54 2277-2286. (doi:10.2337/diabetes.54.8.2277)
4. Chamberlain LH 2001 Inhibition of isoprenoid biosynthesis causes insulin resistance in 3T3-L1 adipocytes. FEBS Letters 507 357-361. (doi:10.1016/S0014-5793(01)03007-1)
5. Comelli F, Bettoni I, Colombo A, Fumagalli P, Giagnoni G & Costa B 2010 Rimonabant, a cannabinoid CB1 receptor antagonist, attenuates mechanical allodynia and counteracts oxidative stress and nerve growth factor deficit in diabetic mice. European Journal of Pharmacology 637 62-69. (doi:10.1016/j.ejphar.2010.03.061)
6. Cota D, Marsicano G, Tschöp M, Grübler Y, Flachskamm C, Schubert M, Auer D, Yassouridis A, Thöne-Reineke C, Ortmann S et al. 2003 The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. Journal of Clinical Investigation 112 423-431.
7. Dalen KT, Ulven SM, Bamberg K, Gustafsson JA & Nebb HI 2003 Expression of the insulin-responsive glucose transporter GLUT4 in adipocytes is dependent on liver X receptor a. Journal of Biological Chemistry 278 48283-48291. (doi:10.1074/jbc.M302287200)
8. Eckardt K, Sell H, Taube A, Koenen M, Platzbecker B, Cramer A, Horrighs A, Lehtonen M, Tennagels N & Eckel J 2009 Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle. Diabetologia 52 664-674. (doi:10.1007/s00125-008-1240-4)
9. Engeli S, Böhnke J, Feldpausch M, Gorzelniak K, Janke J, Bátkai S, Pacher P, Harvey-White J, Luft FC, Sharma AM et al. 2005 Activation of the peripheral endocannabinoid system in human obesity. Diabetes 54 2838-2843. (doi:10.2337/diabetes.54.10.2838)
10. Ferguson RE, Carroll HP, Harris A, Maher ER, Selby PJ & Banks RE 2005 Housekeeping proteins: a preliminary study illustrating some limitations as useful references in protein expression studies. Proteomics 5 566-571. (doi:10.1002/pmic.200400941)
11. Furuya DT, Poletto AC, Favaro RR, Martins JO, Zorn TM & Machado UF 2010 Anti-inflammatory effect of atorvastatin ameliorates insulin resistance in monosodium glutamate-treated obese mice. Metabolism: Clinical and Experimental 59 395-399. (doi:10.1016/j.metabol.2009.08.011)
12. Gasperi V, Fezza F, Pasquariello N, Bari M, Oddi S, Agrò AF & Maccarrone M 2007 Endocannabinoids in adipocytes during differentiation and their role in glucose uptake. Cellular and Molecular Life Sciences 64 219-229. (doi:10.1007/s00018-006-6445-4)
13. Gnudi L, Shepherd PR & Kahn BB 1996 Over-expression of GLUT4 selectively in adipose tissue in transgenic mice: implications for nutrient partitioning. Proceedings of the Nutrition Society 55 191-199. (doi:10.1079/PNS19960020)
14. Hildebrandt AL, Kelly-Sullivan DM & Black SC 2003 Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in dietinduced obese mice. European Journal of Pharmacology 462 125-132. (doi:10.1016/S0014-2999(03)01343-8)
15. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR et al. 2002 International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacological Reviews 54 161-202. (doi:10.1124/pr.54.2.161)
16. Im SS, Kwon SK, Kang SY, Kim TH, Kim HI, Hur MW, Kim KS & Ahn YH 2006 Regulation of GLUT4 gene expression by SREBP-1c in adipocytes. Biochemical Journal 399 131-139. (doi:10.1042/BJ20060696)
17. Ito Y, Pagano PJ, Tornheim K, Brecher P & Cohen RA 1996 Oxidative stress increases glyceraldehyde-3-phosphate dehydrogenase mRNA levels in isolated rabbit aorta. American Journal of Physiology 270 H81-H87.
18. Jbilo O, Ravinet-Trillou C, Arnone M, Buisson I, Bribes E, Péleraux A, Pénarier G, Soubrié P, Le Fur G, Galiègue S et al. 2005 The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance. Journal of the Federation of American Societies for Experimental Biology 19 1-27. (doi:10.1096/fj.04-2370com)
19. Kim JB, Sarraf P, Wright M, Yao KM, Mueller E, Solanes G, Lowell BB & Spiegelman BM 1998 Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. Journal of Clinical Investigation 101 1-9. (doi:10.1172/JCI1411)
20. Lan R, Liu Q, Fan P, Lin S, Fernando SR, McCallion D, Pertwee R & Makriyannis A 1999 Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. Journal of Medicinal Chemistry 42 769-776. (doi:10.1021/jm980363y)
21. Liu YL, Connoley IP, Wilson CA & Stock MJ 2005 Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake inLep(ob)/Lep(ob) mice. International Journal of Obesity 29 183-187. (doi:10.1038/sj.ijo. 0802847)
22. Machado UF, Shimizu Y & Saito M1993 Decreased glucose transporter (GLUT 4) content in insulin-sensitive tissues of obese aurothioglucose-and monosodium glutamate-treated mice. Hormone and Metabolic Research 25 462-465. (doi:10.1055/s-2007-1002149)
23. Machado UF, Shimizu I & Saito M 1994 Reduced content and preserved translocation of glucose transporter (GLUT 4) in white adipose tissue of obese mice. Physiology & Behavior 55 621-625. (doi:10.1016/0031-9384(94)90035-3)
24. Matias I, Gonthier MP, Orlando P, Martiadis V, De Petrocellis L, Cervino C, Petrosino S, Hoareau L, Festy F, Pasquali R et al. 2006 Regulation, function, and dysregulation of endocannabinoids in models of adipose and b-pancreatic cells and in obesity and hyperglycemia. Journal of Clinical Endocrinology and Metabolism 91 3171-3180. (doi:10.1210/jc.2005-2679)
25. Motaghedi R & McGraw TE 2008 The CB1 endocannabinoid system modulates adipocyte insulin sensitivity. Obesity 16 1727-1734. (doi:10.1038/oby.2008.309)
26. Osei-Hyiaman D, DePetrillo M, Pacher P, Liu J, Radaeva S, Bátkai S, Harvey-White J, Mackie K, Offertáler L, Wang L et al. 2005 Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. Journal of Clinical Investigation 115 1298-1305.
27. Pagano C, Pilon C, Calcagno A, Urbanet R, Rossato M, Milan G, Bianchi K, Rizzuto R, Bernante P, Federspil G et al. 2007 The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms. Journal of Clinical Endocrinology and Metabolism 92 4810-4819. (doi:10.1210/jc.2007-0768)
28. Papa PC, Seraphim PM & Machado UF 1997 Loss of weight restores GLUT 4 content in insulin-sensitive tissues of monosodium glutamate-treated obese mice. International Journal of Obesity and Related Metabolic Disorders 21 1065-1070. (doi:10.1038/sj.ijo. 0800517)
29. Perkins ND 2007 Integrating cell-signalling pathways with NF-kB and IKK function. Nature Reviews. Molecular Cell Biology 8 49-62. (doi:10.1038/nrm2083)
30. Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J & RIO-North America Study Group 2006 Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. Journal of the American Medical Association 295 761-775. (doi:10.1001/jama.295.7.761)
31. Ravinet Trillou C, Arnone M, Delgorge C, Gonalons N, Keane P, Maffrand JP & Soubrie P 2003 Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 284 R345-R353.
32. Ruan H, Hacohen N, Golub TR, Van Parijs L & Lodish HF 2002 Tumor necrosis factor-a suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kB activation by TNF-a is obligatory. Diabetes 51 1319-1336. (doi:10.2337/diabetes.51.5.1319)
33. Shimomura I, Bashmakov Y, Shimano H, Horton JD, Goldstein JL & Brown MS 1997 Cholesterol feeding reduces nuclear forms of sterol regulatory element binding proteins in hamster liver. PNAS 94 12354-12359. (doi:10.1073/pnas.94.23.12354)
34. Silva JL, Giannocco G, Furuya DT, Lima GA, Moraes PA, Nachef S, Bordin S, Britto LR, NunesMT & Machado UF 2005 NF-kB, MEF2A, MEF2D and HIF1-a involvement on insulin-and contractioninduced regulation of GLUT4 gene expression in soleus muscle. Molecular and Cellular Endocrinology 240 82-93. (doi:10.1016/j.mce. 2005.05.006)
35. Thorens B, Charron MJ & Lodish HF 1990 Molecular physiology of glucose transporters. Diabetes Care 13 209-218. (doi:10.2337/diacare.13.3.209)
36. Van Gaal LF, Scheen AJ, Rissanen AM, Rössner S, Hanotin C, Ziegler O & RIO-Europe Study Group 2008 Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study. European Heart Journal 29 1761-1771. (doi:10.1093/eurheartj/ehn076)
37. Vettor R & Pagano C 2009 The role of the endocannabinoid system in lipogenesis and fatty acid metabolism. Best Practice & Research. Clinical Endocrinology & Metabolism 23 51-63. (doi:10.1016/j.beem. 2008.10.002)